[Pharmacological and biochemical approach to a syndrome of action and intention myoclonus in the course of degenerative disease of the nervous system]

Rev Neurol (Paris). 1973 May;128(5):323-38.
[Article in French]
No abstract available

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • 5-Hydroxytryptophan / cerebrospinal fluid
  • Adult
  • Benzazepines
  • Cerebellar Ataxia / diagnosis
  • Clinical Trials as Topic
  • Diagnosis, Differential
  • Dibenzazepines
  • Dihydroxyphenylalanine
  • Dopamine beta-Hydroxylase / antagonists & inhibitors
  • Electroencephalography
  • Epilepsy / metabolism
  • Epilepsy / physiopathology*
  • Friedreich Ataxia / diagnosis
  • Humans
  • Hydroxyindoleacetic Acid / cerebrospinal fluid
  • Ketones
  • Male
  • Methyldopa
  • Methysergide
  • Myoclonus / metabolism
  • Myoclonus / physiopathology*
  • Neurotransmitter Agents / metabolism
  • Nitro Compounds
  • Pyridoxine
  • Serotonin / cerebrospinal fluid
  • Synaptic Transmission
  • Tranquilizing Agents

Substances

  • Benzazepines
  • Dibenzazepines
  • Ketones
  • Neurotransmitter Agents
  • Nitro Compounds
  • Tranquilizing Agents
  • Serotonin
  • Hydroxyindoleacetic Acid
  • Methyldopa
  • Dihydroxyphenylalanine
  • 5-Hydroxytryptophan
  • Dopamine beta-Hydroxylase
  • Pyridoxine
  • Methysergide